Why did the G-BA assess Trimbow now?
Trimbow was launched onto the German market in 2017. So why did the G-BA assess its benefit now? You likely know that
Tag: Question time
Negotiated reimbursement price applicable 12 months after launch
G-BA assessments of new indications
The AMNOG law dictates that every pharmaceutical product with a new chemical entity which received its marketing authorization on or after 1
G-BA meetings
Ever wondered if patients influence the G-BA decision-making?
Orphan drug re-assessments
What happens when the sales for an orphan drug exceed €50 mn in a 12 months period?